Differential regulation of cytokine production by PI3Kδ in human monocytes upon acute and chronic inflammatory conditions

Molecular Immunology

Volumn 45, Issue 12, 2008, Pages 3419-3427

  Molnarfi, Nicolas ^a   Brandt, Karim J ^a   Gruaz, Lyssia ^a   Dayer, Jean Michel ^a   Burger, Danielle ^a  

^a Clinical Immunology Unit   (Switzerland)

Author keywords

Cytokines; Human; Inflammation; Monocytes macrophages; Signal transduction

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; NUCLEOTIDE; NUCLEOTIDYLTRANSFERASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENETIC CODE; GENETIC RECOMBINATION; LYMPHOCYTE; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE RECEPTOR GENE; THYMOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACUTE DISEASE; CELL LINE; CELL SEPARATION; CHRONIC DISEASE; CYTOKINES; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISOENZYMES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44749086920     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.04.001     Document Type: Article

References (47)

1. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., and Knaus U.G. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1 (2000) 533-540
2. Barber D.F., Bartolome A., Hernandez C., Flores J.M., Redondo C., Fernandez-Arias C., Camps M., Ruckle T., Schwarz M.K., Rodriguez S., Martinez A., Balomenos D., Rommel C., and Carrera A.C. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 11 (2005) 933-935
3. Beech J.T., Andreakos E., Ciesielski C.J., Green P., Foxwell B.M., and Brennan F.M. T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis. Arthritis Res. Ther. 8 (2006) R168
4. Bommhardt U., Chang K.C., Swanson P.E., Wagner T.H., Tinsley K.W., Karl I.E., and Hotchkiss R.S. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 172 (2004) 7583-7591
5. Brachmann S.M., Ueki K., Engelman J.A., Kahn R.C., and Cantley L.C. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol. Cell. Biol. 25 (2005) 1596-1607
6. Brennan F.M., and Foey A.D. Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions. Arthritis Res. 4 Suppl. 3 (2002) S177-S182
7. Brennan F.M., Hayes A.L., Ciesielski C.J., Green P., Foxwell B.M., and Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum. 46 (2002) 31-41
8. Brunn G.J., Williams J., Sabers C., Wiederrecht G., Lawrence Jr. J.C., and Abraham R.T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15 (1996) 5256-5267
9. Burger D. Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction. Eur. Cytokine Netw. 11 (2000) 346-353
10. Burger D., and Dayer J.M. Interactions between T cell plasma membranes and monocytes. In: Miossec P., van den Berg W.B., and Firestein G.S. (Eds). T Cells in Arthritis (1998), Birkhäuser Verlag, Basel/Switzerland 111-128
11. Burger D., and Dayer J.M. IL-1Ra. In: Oppenheim J.J., and Feldmann M. (Eds). Cytokine Reference (2000), Academic Press, London 319-336
12. Burger D., Molnarfi N., Gruaz L., and Dayer J.M. Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes. J. Immunol. 173 (2004) 1292-1297
13. Burger D., Dayer J.M., and Molnarfi N. Cell contact dependence of inflammatory events. In: Smolen J.S., and Lipsky P.E. (Eds). Contemporary Targeted Therapies in Rheumatology (2007), Taylor and Francis Books Ltd., Abingdon/UK 85-103
14. Camps M., Ruckle T., Ji H., Ardissone V., Rintelen F., Shaw J., Ferrandi C., Chabert C., Gillieron C., Francon B., Martin T., Gretener D., Perrin D., Leroy D., Vitte P.A., Hirsch E., Wymann M.P., Cirillo R., Schwarz M.K., and Rommel C. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11 (2005) 936-943
15. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
16. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
17. Foey A.D., Green P., Foxwell B., Feldmann M., and Brennan F. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis. Arthritis Res. 4 (2002) 64-70
18. Gazdar A.F., Carney D.N., Bunn P.A., Russell E.K., Jaffe E.S., Schechter G.P., and Guccion J.G. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55 (1980) 409-417
19. Guha M., and Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277 (2002) 32124-32132
20. Gutcher I., and Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117 (2007) 1119-1127
21. Hawkins P.T., Anderson K.E., Davidson K., and Stephens L.R. Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34 (2006) 647-662
22. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., and Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 (2000) 1049-1053
23. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000) 86-90
24. Hyka N., Dayer J.M., Modoux C., Kohno T., Edwards C.K.3., Roux-Lombard P., and Burger D. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97 (2001) 2381-2389
25. Izzard R.A., Jackson S.P., and Smith G.C. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res. 59 (1999) 2581-2586
26. Jungo F., Dayer J.M., Modoux C., Hyka N., and Burger D. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine 14 (2001) 272-282
27. Kockeritz L., Doble B., Patel S., and Woodgett J.R. Glycogen synthase kinase-3-an overview of an over-achieving protein kinase. Curr. Drug Targets 7 (2006) 1377-1388
28. Martin M., Schifferle R.E., Cuesta N., Vogel S.N., Katz J., and Michalek S.M. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171 (2003) 717-725
29. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6 (2005) 777-784
30. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., Poliani P.L., Grimaldi L.M., and Comi G. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 109 (2000) 3-9
31. McInnes I.B., and Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7 (2007) 429-442
32. Meyers R., and Cantley L.C. Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase. J. Biol. Chem. 272 (1997) 4384-4390
33. Molnarfi N., Gruaz L., Dayer J.M., and Burger D. Opposite effects of IFNbeta on cytokine homeostasis in LPS- and T cell contact-activated human monocytes. J. Neuroimmunol. 146 (2004) 76-83
34. Molnarfi N., Hyka-Nouspikel N., Gruaz L., Dayer J.M., and Burger D. The production of IL-1 receptor antagonist in IFN-{beta}-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1. J. Immunol. 174 (2005) 2974-2980
35. Molnarfi N., Gruaz L., Dayer J.M., and Burger D. Opposite regulation of IL-1beta and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells. J. Immunol. 178 (2007) 446-454
36. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kase H., and Matsuda Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267 (1992) 2157-2163
37. Ozenci V., Kouwenhoven M., and Link H. Cytokines in multiple sclerosis: methodological aspects and pathogenic implications. Mult. Scler. 8 (2002) 396-404
38. Rommel C., Camps M., and Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat. Rev. Immunol. 7 (2007) 191-201
39. Smeets T.J., Barg E.C., Kraan M.C., Smith M.D., Breedveld F.C., and Tak P.P. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann. Rheum. Dis. 62 (2003) 635-638
40. Tengku-Muhammad T.S., Hughes T.R., Cryer A., and Ramji D.P. Involvement of both the tyrosine kinase and the phosphatidylinositol-3′ kinase signal transduction pathways in the regulation of lipoprotein lipase expression in J774.2 macrophages by cytokines and lipopolysaccharide. Cytokine 11 (1999) 463-468
41. Toker A., and Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 (1997) 673-676
42. Vanhaesebroeck B., Leevers S.J., Panayotou G., and Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22 (1997) 267-272
43. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
44. Weinstein S.L., Finn A.J., Dave S.H., Meng F., Lowell C.A., Sanghera J.S., and DeFranco A.L. Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via interferon-beta. J. Leukoc. Biol. 67 (2000) 405-414
45. Wetzker R., and Rommel C. Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr. Pharm. Des. 10 (2004) 1915-1922
46. Williams D.L., Li C., Ha T., Ozment-Skelton T., Kalbfleisch J.H., Preiszner J., Brooks L., Breuel K., and Schweitzer J.B. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 172 (2004) 449-456
47. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signalling--which way to target?. Trends Pharmacol. Sci. 24 (2003) 366-376